News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,884 Results
Type
Article (42873)
Company Profile (290)
Press Release (693704)
Multimedia
Podcasts (105)
Webinars (21)
Section
Business (206057)
Career Advice (2093)
Deals (35785)
Drug Delivery (134)
Drug Development (81912)
Employer Resources (176)
FDA (16620)
Job Trends (15081)
News (348858)
Policy (32984)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2634)
Accelerated approval (48)
Adcomms (28)
Allergies (171)
Alliances (49994)
ALS (213)
Alzheimer's disease (1812)
Antibody-drug conjugate (ADC) (467)
Approvals (17008)
Artificial intelligence (679)
Autoimmune disease (298)
Automation (56)
Bankruptcy (365)
Best Places to Work (11674)
BIOSECURE Act (22)
Biosimilars (225)
Biotechnology (185)
Bladder cancer (199)
Brain cancer (72)
Breast cancer (760)
Cancer (5905)
Cardiovascular disease (482)
Career advice (1783)
Career pathing (43)
CAR-T (337)
CDC (57)
Celiac Disease (3)
Cell therapy (919)
Cervical cancer (47)
Clinical research (71197)
Collaboration (2101)
Company closure (5)
Compensation (1410)
Complete response letters (81)
COVID-19 (2769)
CRISPR (110)
C-suite (1150)
Cystic fibrosis (154)
Data (8029)
Decentralized trials (3)
Denatured (34)
Depression (164)
Dermatology (88)
Diabetes (591)
Diagnostics (6964)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (331)
Drug pricing (206)
Drug shortages (31)
Duchenne muscular dystrophy (289)
Earnings (92352)
Editorial (69)
Employer branding (21)
Employer resources (153)
Events (120394)
Executive appointments (1093)
FDA (20389)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1755)
Gene editing (239)
Generative AI (57)
Gene therapy (731)
GLP-1 (1076)
Government (4771)
Grass and pollen (6)
Guidances (409)
Healthcare (19092)
HIV (80)
Huntington's disease (59)
IgA nephropathy (97)
Immunology and inflammation (297)
Immuno-oncology (95)
Indications (196)
Infectious disease (3118)
Inflammatory bowel disease (221)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (294)
Interviews (338)
IPO (16730)
IRA (52)
Job creations (3705)
Job search strategy (1470)
JPM (58)
Kidney cancer (19)
Labor market (104)
Layoffs (578)
Leadership (42)
Legal (8028)
Liver cancer (100)
Longevity (33)
Lung cancer (777)
Lymphoma (432)
Machine learning (60)
Management (60)
Manufacturing (1069)
MASH (190)
Medical device (14031)
Medtech (14159)
Mergers & acquisitions (20312)
Metabolic disorders (1530)
mRNA (214)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (425)
Neuropsychiatric disorders (107)
Neuroscience (3344)
Neurotech (1)
NextGen: Class of 2026 (6584)
Non-profit (4548)
Now hiring (78)
Obesity (721)
Opinion (297)
Ovarian cancer (227)
Pain (259)
Pancreatic cancer (312)
Parkinson's disease (365)
Partnered (35)
Patents (603)
Patient recruitment (682)
Peanut (62)
People (60050)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22185)
Phase 2 (31360)
Phase 3 (23326)
Pipeline (8931)
Policy (325)
Postmarket research (2603)
Preclinical (9475)
Press Release (64)
Prostate cancer (308)
Psychedelics (55)
Radiopharmaceuticals (326)
Rare diseases (1095)
Real estate (6023)
Recruiting (70)
Regulatory (25604)
Reports (59)
Research institute (2431)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (26)
RSV (88)
Schizophrenia (178)
Series A (297)
Series B (216)
Service/supplier (13)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3711)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (90)
The Weekly (68)
Vaccines (1107)
Venture capital (114)
Weight loss (469)
Women's health (128)
Worklife (20)
Date
Today (21)
Last 7 days (653)
Last 30 days (3280)
Last 365 days (30267)
2026 (13189)
2025 (30371)
2024 (35368)
2023 (40234)
2022 (51363)
2021 (55920)
2020 (54269)
2019 (46752)
2018 (35234)
2017 (32313)
2016 (31756)
2015 (37815)
2014 (31602)
2013 (26642)
2012 (28932)
2011 (29569)
2010 (27718)
Location
Africa (753)
Alabama (93)
Alaska (7)
Arizona (353)
Arkansas (14)
Asia (40135)
Australia (6627)
California (13464)
Canada (3805)
China (1367)
Colorado (571)
Connecticut (580)
Delaware (412)
Europe (87077)
Florida (2009)
Georgia (430)
Hawaii (3)
Idaho (63)
Illinois (1064)
India (91)
Indiana (605)
Iowa (23)
Japan (541)
Kansas (132)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1603)
Massachusetts (9591)
Michigan (366)
Minnesota (732)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (85)
New Jersey (3520)
New Mexico (29)
New York (3500)
North Carolina (1705)
North Dakota (9)
Northern California (6762)
Ohio (402)
Oklahoma (23)
Oregon (43)
Pennsylvania (2694)
Puerto Rico (29)
Rhode Island (50)
South America (1124)
South Carolina (86)
South Dakota (2)
Southern California (5310)
Tennessee (215)
Texas (2146)
United States (47385)
Utah (399)
Vermont (1)
Virginia (324)
Washington D.C. (81)
Washington State (1073)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
736,884 Results for "pressure biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 13, 2026
·
3 min read
Cardiovascular disease
Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout
While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting advancement into Phase 2b.
March 30, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
·
17 min read
Press Releases
Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update
May 11, 2026
·
7 min read
Press Releases
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
May 5, 2026
·
7 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Press Releases
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
May 20, 2026
·
3 min read
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
April 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - May 11, 2026
May 12, 2026
·
1 min read
1 of 73,689
Next
